The Director, Early Pipeline Commercialization is key role in SBU's Oncology Strategy and EPC group responsible for developing commercialization strategies to maximize the value of Oncology early pipeline assets. This role is a strategic role that requires ability and experience to provide commercial leadership through internal and external inputs and prepare the team for key milestone discussions/ decisions. This entails in-depth understanding and ability to analyze the global oncology market in significant depth across multiple tumors, each being across multiple lines with the added complexity of mono therapy and combination along with biomarkers. Additionally, this role is responsible for developing and maintaining robust business plans for select early pipeline projects and ensure commercial inputs to asset and portfolio decisions.
This role supports strategy development for maximizing long term value of asset portfolio and owns competitive landscape analysis to identify opportunities and emerging risks for the early franchise assets. This role also proactively works with medical affairs to engage with external experts to increase pipeline awareness. Develops product life cycle management strategy for the assigned product / group to maximize enterprise value, based on continuous evaluation of competitive market landscapes in cross-functional teams including strategic marketing, clinical development, regulatory, medical affairs, market research, and external cooperation partners.
YOUR TASKS AND RESPONSIBILITIES
The primary responsibilities of this role, Director of Early Pipeline Commercialization, are to:
Lead commercialization strategies to maximize the value of Oncology early pipeline assets in partnership with sr. directors;
Lead strategy and Early Pipeline Commercialization(EPC) special projects as assigned;
Be accountable for the process to provide high quality, insights driven competitive intelligence and market research (secondary and primary) in collaboration with the CBI team;
Be accountable for the process for the Oncology Strategic Business Unit (SBU) congress presence and coverage in collaboration with the medical affairs team;
Provide analytical and research support (Market Research, CI, Forecasting etc.) for asset advancement decisions based on a comprehensive evaluation of pipeline assets against competition and standard of care (current and future);
Support business case development including development of options spaces for asset strategy asset prioritization decisions (commercial evidence and relevance-based go/no-go, indication prioritization, etc.);
Work collaboratively with key functional stakeholders (BD&L, Research and Development (R&D), Regulatory, Market Access, etc.) to assist in commercial evaluation and business case development for in-licensing and Mergers and Acquisitions (M&A) opportunities;
Provide project and account management support for key vendor and consulting partners on assignment;
Lead budgeting for Early Pipeline Commercialization(EPC) and strategy group.
WHO YOU ARE
Your success will be driven by your demonstration of our LIFE values. More specifically related to this position, Bayer seeks an incumbent who possesses the following:
Bachelor of Science in Business Administration in Sciences (pharmaceutical, biology, chemistry, etc.) with at least 10 years of experience preferably in marketing including established and new product responsibilities or business development in the Pharmaceutical Industry;or Master of Business Administration (M.B.A) or Ph.D with at least 8 years of experience;
Identify and accurately evaluate current and new competitive products development activities in the worldwide pharmaceutical marketplace applying this knowledge to maximize potential for assigned products;
Demonstrated leadership, negotiation, strategic insights to interact with all levels of global teams;
Demonstrated strong analytical and problem-solving skills to develop complex proposals;
Excellent written and verbal communication skills;
The incumbent must have strong multi-tasking and organization skills, knowledge of market conditions, and business cultures;
The incumbent must have demonstrated creativity in problem solving and ability to work independently as well as the ability to function effectively and collaboratively in cross-functional teams;
Ability to travel domestically and internationally up to 20% annually.
Master of Business Administration (M.B.A) and/or advanced degree (Master's degree/Ph.D.) and experience of working in oncology development teams;
International and US experience;
At least fiveyears of experience working with Precision Medicine and/or Immuno Oncology assets;
Management consulting or investment banking experience.
Bayer is an Equal Opportunity Employer/Disabled/Veterans